Early versus delayed or no empagliflozin initiation after hospitalization for heart failure in the United States: a target trial emulation
Abstract Background and Aims Sodium-glucose cotransporter-2 inhibitors (SGLT2is) are a foundational therapy for heart failure (HF), yet initiation is frequently delayed in clinical practice. Data comparing outcomes associated with early versus delayed or no initiation of SGLT2is following hospitalization for heart fail...